These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 25547954)

  • 1. French health insurance databases: What interest for medical research?
    Moulis G; Lapeyre-Mestre M; Palmaro A; Pugnet G; Montastruc JL; Sailler L
    Rev Med Interne; 2015 Jun; 36(6):411-7. PubMed ID: 25547954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of a national administrative database to guide public decisions: From the système national d'information interrégimes de l'Assurance Maladie (SNIIRAM) to the système national des données de santé (SNDS) in France.
    Tuppin P; Rudant J; Constantinou P; Gastaldi-Ménager C; Rachas A; de Roquefeuil L; Maura G; Caillol H; Tajahmady A; Coste J; Gissot C; Weill A; Fagot-Campagna A
    Rev Epidemiol Sante Publique; 2017 Oct; 65 Suppl 4():S149-S167. PubMed ID: 28756037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. French Medical-Administrative Database for Epidemiology and Safety in Ophthalmology (EPISAFE): The EPISAFE Collaboration Program in Cataract Surgery.
    Daien V; Korobelnik JF; Delcourt C; Cougnard-Gregoire A; Delyfer MN; Bron AM; Carrière I; Villain M; Daures JP; Lacombe S; Mariet AS; Quantin C; Creuzot-Garcher C
    Ophthalmic Res; 2017; 58(2):67-73. PubMed ID: 28376478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. French national health insurance information system and the permanent beneficiaries sample.
    Tuppin P; de Roquefeuil L; Weill A; Ricordeau P; Merlière Y
    Rev Epidemiol Sante Publique; 2010 Aug; 58(4):286-90. PubMed ID: 20598822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and economic burden of cardiovascular diseases in France in 2013 according to the national health insurance scheme database.
    Tuppin P; Rivière S; Rigault A; Tala S; Drouin J; Pestel L; Denis P; Gastaldi-Ménager C; Gissot C; Juillière Y; Fagot-Campagna A
    Arch Cardiovasc Dis; 2016; 109(6-7):399-411. PubMed ID: 27079468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use in France of Baclofen for Alcohol Dependence from 2007 to 2013: Cohort Study Based on the Databases SNIIRAM and PMSI].
    Chaignot C; Weill A; Ricordeau P; Alla F
    Therapie; 2015; 70(5):443-53. PubMed ID: 26423143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton pump inhibitors prescriptions in France: Main trends from 2006 to 2016 on French health insurance database.
    Boucherie Q; Rouby F; Frankel D; Roll P; Micallef J
    Therapie; 2018 Oct; 73(5):385-388. PubMed ID: 29778306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The French Pregnancy Cohort: Medication use during pregnancy in the French population.
    Bérard A; Abbas-Chorfa F; Kassai B; Vial T; Nguyen KA; Sheehy O; Schott AM
    PLoS One; 2019; 14(7):e0219095. PubMed ID: 31314794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology.
    Bezin J; Duong M; Lassalle R; Droz C; Pariente A; Blin P; Moore N
    Pharmacoepidemiol Drug Saf; 2017 Aug; 26(8):954-962. PubMed ID: 28544284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Performing pharmacoepidemiological studies using the French health insurance data warehouse (SNDS): How to translate guidelines into practice].
    de Germay S; Conte C; Micallef J; Bouquet E; Chouchana L; Lafaurie M; Pariente A;
    Therapie; 2023; 78(6):691-703. PubMed ID: 36841652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Off-label prescriptions: how to identify them, frame them, announce them and monitor them in practice?
    Le Jeunne C; Billon N; Dandon A; ; Berdaï D; Adgibi Y; Bergmann JF; Bordet R; Carpentier A; Cohn E; Courcier S; Girault D; Goni S; Jolliet P; Liard F; Prot-Labarthe S; Simon T; Vernotte C; Westerloppe J
    Therapie; 2013; 68(4):225-39. PubMed ID: 23981260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive predictive values of selected hospital discharge diagnoses to identify infections responsible for hospitalization in the French national hospital database.
    Sahli L; Lapeyre-Mestre M; Derumeaux H; Moulis G
    Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):785-9. PubMed ID: 27125251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of algorithms to identify incident cancer cases by using French health administrative databases.
    Ajrouche A; Estellat C; De Rycke Y; Tubach F
    Pharmacoepidemiol Drug Saf; 2017 Aug; 26(8):935-944. PubMed ID: 28485129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentially inappropriate drug prescription in the elderly in France: a population-based study from the French National Insurance Healthcare system.
    Bongue B; Laroche ML; Gutton S; Colvez A; Guéguen R; Moulin JJ; Merle L
    Eur J Clin Pharmacol; 2011 Dec; 67(12):1291-9. PubMed ID: 21691806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does insulin glargine increase the risk of cancer compared with other basal insulins?: A French nationwide cohort study based on national administrative databases.
    Fagot JP; Blotière PO; Ricordeau P; Weill A; Alla F; Allemand H
    Diabetes Care; 2013 Feb; 36(2):294-301. PubMed ID: 22966091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the French national health insurance information system for research in the field of mental health: Systematic review and perspectives.
    Revet A; Moulis G; Raynaud JP; Bui E; Lapeyre-Mestre M
    Fundam Clin Pharmacol; 2022 Feb; 36(1):16-34. PubMed ID: 33998708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-national health care database utilization between Spain and France: results from the EPICHRONIC study assessing the prevalence of type 2 diabetes mellitus.
    Moulis G; Ibañez B; Palmaro A; Aizpuru F; Millan E; Lapeyre-Mestre M; Sailler L; Cambra K
    Clin Epidemiol; 2018; 10():863-874. PubMed ID: 30100760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug use in French children: a population-based study.
    Bénard-Laribière A; Jové J; Lassalle R; Robinson P; Droz-Perroteau C; Noize P
    Arch Dis Child; 2015 Oct; 100(10):960-5. PubMed ID: 25977563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacoepidemiological research using French reimbursement databases: yes we can!
    Martin-Latry K; Bégaud B
    Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):256-65. PubMed ID: 20128015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of drug data within French health insurance databases and implications for pharmacoepidemiological studies.
    Palmaro A; Moulis G; Despas F; Dupouy J; Lapeyre-Mestre M
    Fundam Clin Pharmacol; 2016 Dec; 30(6):616-624. PubMed ID: 27351637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.